| Seer is a life sciences company focused on capturing molecular insights from the proteome to enable insights in the understanding of biology and disease. Co. has focused its efforts mainly to research, development and commercialization of its technology and products. Co.'s product, the Proteograph Product Suite (Proteograph), uses its proprietary engineered nanoparticle technology to provide access to the proteome. The Proteograph Product Suite is an integrated solution that is comprised of consumables, an automation instrument and software. Co. is initially focused on research applications for the Proteograph Product Suite and is selling and marketing the Proteograph for research use only. The SEER YTD return is shown above.
The YTD Return on the SEER YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether SEER YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SEER YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.